HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Early changes in clinical, functional, and laboratory biomarkers in workers at risk of indium lung disease.

AbstractRATIONALE:
Occupational exposure to indium compounds, including indium-tin oxide, can result in potentially fatal indium lung disease. However, the early effects of exposure on the lungs are not well understood.
OBJECTIVES:
To determine the relationship between short-term occupational exposures to indium compounds and the development of early lung abnormalities.
METHODS:
Among indium-tin oxide production and reclamation facility workers, we measured plasma indium, respiratory symptoms, pulmonary function, chest computed tomography, and serum biomarkers of lung disease. Relationships between plasma indium concentration and health outcome variables were evaluated using restricted cubic spline and linear regression models.
MEASUREMENTS AND MAIN RESULTS:
Eighty-seven (93%) of 94 indium-tin oxide facility workers (median tenure, 2 yr; median plasma indium, 1.0 μg/l) participated in the study. Spirometric abnormalities were not increased compared with the general population, and few subjects had radiographic evidence of alveolar proteinosis (n = 0), fibrosis (n = 2), or emphysema (n = 4). However, in internal comparisons, participants with plasma indium concentrations ≥ 1.0 μg/l had more dyspnea, lower mean FEV1 and FVC, and higher median serum Krebs von den Lungen-6 and surfactant protein-D levels. Spline regression demonstrated nonlinear exposure response, with significant differences occurring at plasma indium concentrations as low as 1.0 μg/l compared with the reference. Associations between health outcomes and the natural log of plasma indium concentration were evident in linear regression models. Associations were not explained by age, smoking status, facility tenure, or prior occupational exposures.
CONCLUSIONS:
In indium-tin oxide facility workers with short-term, low-level exposure, plasma indium concentrations lower than previously reported were associated with lung symptoms, decreased spirometric parameters, and increased serum biomarkers of lung disease.
AuthorsKristin J Cummings, M Abbas Virji, Bruce C Trapnell, Brenna Carey, Terrance Healey, Kathleen Kreiss
JournalAnnals of the American Thoracic Society (Ann Am Thorac Soc) Vol. 11 Issue 9 Pg. 1395-403 (Nov 2014) ISSN: 2325-6621 [Electronic] United States
PMID25295756 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Biomarkers
  • MUC1 protein, human
  • Mucin-1
  • Pulmonary Surfactant-Associated Protein D
  • Tin Compounds
  • indium tin oxide
Topics
  • Adult
  • Asthma (epidemiology)
  • Biomarkers (blood)
  • Dyspnea (epidemiology)
  • Female
  • Forced Expiratory Volume
  • Humans
  • Male
  • Middle Aged
  • Mucin-1 (blood)
  • Occupational Exposure (adverse effects, analysis)
  • Pulmonary Alveolar Proteinosis (diagnostic imaging)
  • Pulmonary Surfactant-Associated Protein D (blood)
  • Radiography
  • Respiratory Sounds
  • Spirometry
  • Tin Compounds (blood, toxicity)
  • United States (epidemiology)
  • Vital Capacity

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: